Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients

This publication has 22 references indexed in Scilit:

• Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI
  European Journal Of Cancer, 1998
• Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications
  Breast Cancer Research and Treatment, 1997
• Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.
  Journal of Clinical Oncology, 1996
• Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancer
  European Journal Of Cancer, 1993
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
  The Lancet, 1992
• Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer
  British Journal of Cancer, 1991
• Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial.
  Journal of Clinical Oncology, 1990
• Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An eastern cooperative oncology group trial
  Cancer, 1990
• Adjuvant chemotherapy in premenopausal patients with primary breast cancer; relation to drug-induced amenorrhoea, age and the progesterone receptor status of the tumour
  European Journal of Cancer and Clinical Oncology, 1988
• CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL FOR BREAST CANCER
  The Lancet, 1984